Oppenheimer Maintains Outperform on Biomea Fusion, Maintains $70 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Hartaj Singh maintains an Outperform rating on Biomea Fusion (NASDAQ:BMEA) and keeps the price target at $70.
April 03, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer analyst Hartaj Singh reaffirms an Outperform rating on Biomea Fusion with a $70 price target.
The reaffirmation of an Outperform rating and a $70 price target by a reputable analyst like Hartaj Singh suggests a positive outlook for Biomea Fusion's stock. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100